$8.81
0[0.00%]
At close: Apr 18
$8.81
0[0.00%]
After Hours: 4:00PM EDT
Pediatrix Medical Group
(NYSE:MD)Pediatrix Medical Group Stock (NYSE:MD), Analyst Ratings, Price Targets, Predictions
Pediatrix Medical Group Inc has a consensus price target of $19.59, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from Jefferies, Mizuho, and Truist Securities on March 6, 2024, February 21, 2024, and February 21, 2024. With an average price target of $9.33 between Jefferies, Mizuho, and Truist Securities, there's an implied 5.94% upside for Pediatrix Medical Group Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
Mizuho
Truist Securities
UBS
Credit Suisse
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Pediatrix Medical Group
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/06/2024 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 2.16% | Jefferies | Brian Tanquilut | $10 → $9 | Maintains | Hold | Get Alert |
| 02/21/2024 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 2.16% | Mizuho | Ann Hynes | $10 → $9 | Maintains | Neutral | Get Alert |
| 02/21/2024 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 13.51% | Truist Securities | David Macdonald | $10.5 → $10 | Maintains | Hold | Get Alert |
| 11/30/2023 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 7.83% | UBS | A.J. Rice | → $9.5 | Initiates | → Neutral | Get Alert |
| 10/11/2023 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 70.26% | Truist Securities | David Macdonald | $16 → $15 | Maintains | Hold | Get Alert |
| 05/09/2023 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 70.26% | Truist Securities | David Macdonald | $17 → $15 | Maintains | Hold | Get Alert |
| 02/22/2023 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 161.07% | Credit Suisse | Jonathan Yon | $27 → $23 | Maintains | Outperform | Get Alert |
| 12/05/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 206.47% | Credit Suisse | Jonathan Yon | $28 → $27 | Maintains | Outperform | Get Alert |
| 11/16/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 92.96% | Mizuho | Ann Hynes | $21 → $17 | Maintains | Neutral | Get Alert |
| 11/04/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 81.61% | SVB Leerink | Whit Mayo | $20 → $16 | Maintains | Market Perform | Get Alert |
| 08/11/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 217.82% | Credit Suisse | A.J. Rice | $30 → $28 | Maintains | Outperform | Get Alert |
| 08/10/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 161.07% | BMO Capital | Matt Borsch | $25 → $23 | Maintains | Market Perform | Get Alert |
| 05/12/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 127.01% | SVB Leerink | Whit Mayo | $24 → $20 | Maintains | Market Perform | Get Alert |
| 05/03/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 240.52% | Credit Suisse | Jonathan Yong | $31 → $30 | Maintains | Outperform | Get Alert |
| 05/02/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 161.07% | Mizuho | Ann Hynes | $28 → $23 | Maintains | Neutral | Get Alert |
| 04/27/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 172.42% | SVB Leerink | Whit Mayo | $27 → $24 | Maintains | Market Perform | Get Alert |
| 02/23/2022 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 251.87% | Credit Suisse | A.J. Rice | $32 → $31 | Maintains | Outperform | Get Alert |
| 12/22/2021 | MD | Buy Now | Pediatrix Medical Group | $8.81 | 263.22% | Credit Suisse | Jonathan Yon | $33 → $32 | Maintains | Outperform | Get Alert |
| 11/04/2021 | MD | Buy Now | Mednax | $8.81 | 206.47% | SVB Leerink | Whit Mayo | — | Maintains | Market Perform | Get Alert |
FAQ
What is the target price for Pediatrix Medical Group (MD)?
The latest price target for Pediatrix Medical Group (NYSE: MD) was reported by Jefferies on March 6, 2024. The analyst firm set a price target for $9.00 expecting MD to rise to within 12 months (a possible 2.16% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pediatrix Medical Group (MD)?
The latest analyst rating for Pediatrix Medical Group (NYSE: MD) was provided by Jefferies, and Pediatrix Medical Group maintained their hold rating.
When was the last upgrade for Pediatrix Medical Group (MD)?
There is no last upgrade for Pediatrix Medical Group.
When was the last downgrade for Pediatrix Medical Group (MD)?
There is no last downgrade for Pediatrix Medical Group.
When is the next analyst rating going to be posted or updated for Pediatrix Medical Group (MD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pediatrix Medical Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pediatrix Medical Group was filed on March 6, 2024 so you should expect the next rating to be made available sometime around March 6, 2025.
Is the Analyst Rating Pediatrix Medical Group (MD) correct?
While ratings are subjective and will change, the latest Pediatrix Medical Group (MD) rating was a maintained with a price target of $10.00 to $9.00. The current price Pediatrix Medical Group (MD) is trading at is $8.81, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.